Irbesartan and Escitalopram drug interactions - from FDA reports


Drug interactions are reported among people who take Irbesartan and Escitalopram together. This study is created by eHealthMe based on reports of 219 people who take Irbesartan and Escitalopram from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.



On Feb, 08, 2019

219 people who take Irbesartan, Escitalopram are studied.


Number of reports submitted per year:

Irbesartan and Escitalopram drug interactions.

Most common drug interactions over time *:

< 1 month:
  1. Fall
  2. Asthenia (weakness)
  3. Blood potassium decreased
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Dizziness
  6. Poverty of speech
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Dyspnoea (difficult or laboured respiration)
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Oedema mouth (swelling of mouth)
1 - 6 months:
  1. Balance disorder
  2. Confusional state
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Agitation (state of anxiety or nervous excitement)
  5. Daydreaming
  6. Death
  7. Dysarthria (speech disorder)
  8. Fear of eating
  9. Gait disturbance
  10. Gastroduodenal ulcer
6 - 12 months:
  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Amylase increased
  3. Biliary tract disorder
  4. Lipase increased
  5. Pancreatic disorder
1 - 2 years:
  1. Lung infection
  2. Nausea (feeling of having an urge to vomit)
  3. Nephrolithiasis (calculi in the kidneys)
  4. Pneumonia
  5. Pyelonephritis (inflammation of kidney caused by bacteria)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Atrioventricular block second degree (heart block second degree)
  8. Chest pain
  9. Chronic kidney disease
2 - 5 years:
  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Deafness
  3. Dizziness
  4. Influenza
  5. Nausea (feeling of having an urge to vomit)
  6. Syncope (loss of consciousness with an inability to maintain postural tone)
  7. Vomiting
5 - 10 years:

n/a

10+ years:

n/a

not specified:
  1. Abdominal pain
  2. Apathy
  3. Dyspnoea (difficult or laboured respiration)
  4. Haemoglobin decreased
  5. Lethargy (tiredness)
  6. Oliguria (not enough urine)
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Hypotension (abnormally low blood pressure)
  9. Insomnia (sleeplessness)
  10. Weight decreased

Most common drug interactions by gender *:

female:
  1. Glaucoma (increased fluid pressure in the eye with vision loss)
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Dehydration (dryness resulting from the removal of water)
  4. Fatigue (feeling of tiredness)
  5. Hepatocellular injury (liver injury)
  6. Therapeutic agent toxicity (poisoning by ability to cure substance)
  7. Apathy
  8. Blood creatinine increased
  9. Lethargy (tiredness)
  10. Oliguria (not enough urine)
male:
  1. Dizziness
  2. Hypotension (abnormally low blood pressure)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Nausea (feeling of having an urge to vomit)
  5. Somnolence (a state of near-sleep, a strong desire for sleep)
  6. Fall
  7. Agitation (state of anxiety or nervous excitement)
  8. Anaemia (lack of blood)
  9. Back pain
  10. Decreased appetite

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

40-49:
  1. Fall
  2. Hypotension (abnormally low blood pressure)
  3. Adjustment disorder with depressed mood
  4. Agitation (state of anxiety or nervous excitement)
  5. Feeling of despair
  6. Multiple drug overdose
  7. Renal impairment (severely reduced kidney function)
  8. Suicidal ideation
  9. Atrioventricular block second degree (heart block second degree)
  10. Breast cancer
50-59:
  1. Insomnia (sleeplessness)
  2. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  3. Anaemia (lack of blood)
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Intentional overdose
  7. Multiple drug overdose intentional
  8. Agitation (state of anxiety or nervous excitement)
  9. Daydreaming
  10. Death
60+:
  1. Diarrhoea
  2. Confusional state
  3. Dysarthria (speech disorder)
  4. Glaucoma (increased fluid pressure in the eye with vision loss)
  5. Blood creatinine increased
  6. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  7. Dehydration (dryness resulting from the removal of water)
  8. Drug ineffective
  9. Hepatocellular injury (liver injury)
  10. Therapeutic agent toxicity (poisoning by ability to cure substance)

* Approximation only. Some reports may have incomplete information.

Do you take Irbesartan and Escitalopram?


You are not alone:




Related studies

Irbesartan

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. (latest outcomes from Irbesartan 16,059 users)

Escitalopram

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. (latest outcomes from Escitalopram 31,649 users)


Browse by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Irbesartan and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Escitalopram and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Irbesartan and Escitalopram
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Irbesartan and Escitalopram (17,410 reports studied)

FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!